|
Table of Contents |
|
UK Critical Illness and Income Protection 2007 - Examines the markets for Critical Illness and Income Protection in the UK, looking at the relative sizes of the markets and assessing the future of these protection products
Product Code: dmfs2013
Publication Date: 19-Jun-2007
Overview
Introduction
Examines the markets for Critical Illness and Income Protection in the UK, looking at the relative sizes of the markets and assessing the future of these protection products
Scope
· This report provides a comprehensive analysis of the individual Income Protection and individual Critical Illness Insurance markets
· Assesses the factors that have driven these markets to their current levels and forecasts premium income growth in the individual protection market
· Looks at the Income protection and Critical Illness markets in terms of new business, number of policies sold and distribution
Report Highlights
In 2006, new business premiums in IP stood at GBP50m, compared to total CII sales of GBP287m. However, sales of stand-alone CII products were only valued at GBP36m in 2006, thus lower than IP sales. It is as a rider product that sales of CII are vastly outstripping IP.
The ABI is implementing changes which include a new standard description of CI to help ensure that consumers see a consistent explanation of the product; ensuring that, even if consumers do not read the full definitions, they will get a much clearer view about what is covered and what is not.
The Income Protection Taskforce has developed a series of recommendations including suggestions on improved underwriting, marketing and better enforcement of regulations
Reasons to Purchase
· Provides historic and forecast data for the UK individual protection market.
· Utilizes in-depth primary research to provide the answers to how the markets have arrived at the point they have and what the future holds.
· Identifies areas and product features where and where development is needed if these products are to continue to survive.
|
Overview |
1 |
|
Catalyst |
1 |
|
Summary |
1 |
|
Methodology |
1 |
|
Executive Summary |
2 |
|
Market Focus |
2 |
|
This report examines the UK individual Income Protection and Critical Illness Insurance market |
2 |
|
New business premiums in IP products are higher than in stand-alone CII products |
2 |
|
Sector Issues |
2 |
|
The ABI introduced a new and improved Statement of Best Practice for Critical Illness Cover. |
2 |
|
The Income Protection Taskforce has developed a series of recommendations |
2 |
|
Competitor Issues |
3 |
|
In CII, the top 5 players share more than 50% of the UK market among them |
3 |
|
In IP, the top 5 players share almost two-thirds of the UK market among them |
3 |
|
Distribution Dynamics |
3 |
|
Despite not being such a profitable sale for them, IFAs dominate distribution of both income protection and critical illness products |
3 |
|
Table of Contents |
4 |
|
Table of figures |
5 |
|
Table of tables |
6 |
|
Market Focus |
7 |
|
This report examines the UK individual Income Protection and Critical Illness Insurance market |
7 |
|
The report will be useful for those responsible for developing the strategic direction of competitors in the income protection market |
7 |
|
What are Critical Illness products? |
7 |
|
With rider Critical Illness |
8 |
|
Stand-alone Critical Illness |
8 |
|
What are Income Protection products? |
8 |
|
Income Protection continues to play a niche role in the UK protection market |
9 |
|
The Income Protection Gap widens but hope still remains that various initiatives might encourage distributors to turn to IP |
9 |
|
New business premiums in IP products are higher than in stand-alone CII products |
10 |
|
Both CII and IP continue to see declining sales in terms of policy numbers |
11 |
|
The number of policies sold in both accelerated and standalone CII have fallen |
11 |
|
Individual IP sales saw further declines in 2005 but not as strong as a year earlier |
12 |
|
Business in force is an important measurement of lapse rates in the market |
14 |
|
Despite relatively poor performance in terms of new business, the value of business in force in the income protection market has grown |
14 |
|
Critical illness business in force has declined, despite steady new business figures |
15 |
|
The total UK protection market is forecast to grow by a compound annual rate of 2.6% between 2007 and 2011 |
17 |
|
Sector Issues |
19 |
|
The ABI introduced a new and improved Statement of Best Practice for Critical Illness Cover |
19 |
|
Industry experts are positive about the new CI definitions |
20 |
|
Many IFAs feel they were left in the dark on CI changes |
20 |
|
The issue of non-disclosure could be tackled by the Law Commission's review of insurance contract law |
21 |
|
The Income Protection Task Force seeks to raise awareness about Income Protection Insurance |
21 |
|
The Income Protection Taskforce has developed a series of recommendations |
21 |
|
Application and underwriting should be re-engineered |
21 |
|
The product design should be rethought and revised |
21 |
|
Regulation such as ICOB and TCF should be enforced thoroughly |
22 |
|
The move towards 'essential expenses' is seen as a sensible solution |
22 |
|
Tele-interviews could be carried out by outsourced specialists |
23 |
|
Consumer awareness could be improved with the help of media |
23 |
|
Advisor awareness could be improved with the help of trade associations |
23 |
|
The industry should seek a holistic approach that includes State and private benefits |
24 |
|
Standardization of non-competitively sensitive aspects |
24 |
|
Income protection has huge potential but is still a relatively complicated product |
24 |
|
TCF and ICOB could potentially improve the sale of income protection |
25 |
|
Competitor Issues |
27 |
|
In CII, the top 5 players share more than 50% of the UK market among them |
27 |
|
In IP, the top 5 players share almost two-thirds of the UK market among them |
28 |
|
Providers try to adapt and enhance their products to meet regulator and customer needs |
30 |
|
Friends Provident made some key enhancements with regards to its Income Protection products |
30 |
|
Legal & General developed a new approach for the group protection market |
30 |
|
Legal & General announced rise in critical claims payments and new CI product |
31 |
|
Norwich Union reported critical illness product changes and rise in claims paid |
32 |
|
Prudential introduced its innovative critical illness cover to the broader IFA community |
33 |
|
Pioneer redefined own-occupation and started a series of seminars to highlight the importance of IP |
33 |
|
Bright Grey introduced four new illnesses to its critical illness cover |
34 |
|
A number of providers have changed their critical illness maximum cover |
34 |
|
Distribution Dynamics |
35 |
|
IFAs continue to dominate the income protection market |
35 |
|
After an initial surge, new business of critical illness through tied channels has declined since 2004 |
37 |
|
Multi-tied financial advisors are forecast to seize a reasonable proportion of the income protection market over the next 5 years. |
38 |
|
IFAs will retain their dominance of the stand alone critical illness market |
40 |
|
Appendix |
43 |
|
Definitions |
43 |
|
Products |
43 |
|
Income Protection |
43 |
|
Critical Illness |
43 |
|
ABI definitions of distribution channels |
43 |
|
Independent Financial Advisors (IFAs) |
43 |
|
Direct sales forces |
43 |
|
Tied agents |
43 |
|
Multi-tied agents |
43 |
|
Bancassurance |
43 |
|
Direct marketing |
44 |
|
Telesales |
44 |
|
Other |
44 |
|
Further reading |
44 |
|
Ask the analyst |
44 |
|
Datamonitor consulting |
44 |
|
Disclaimer |
44 |
|
List of Tables |
|
|
Table 1: New business premiums in individual protection, 2002-2006, £m APE |
11 |
|
Table 2: Total number of premium sales for individual IP and individual CI policies, 2002-2005 |
13 |
|
Table 3: Income protection new business vs business in force 2001-2005 |
15 |
|
Table 4: Critical Illness new business vs business in force, 2001-2005 £m |
16 |
|
Table 5: Forecast individual protection products 2007-2011, £m |
18 |
|
Table 6: Top 5 players in the CII market in terms of numbers of policies sold in 2005 and previous ranking |
28 |
|
Table 7: Top 5 players in the IP market in terms of numbers of policies sold in 2005 and previous ranking |
29 |
|
Table 8: Income protection distribution 2002-2006, £m APE |
36 |
|
Table 9: Stand alone Critical illness distribution 2002-2006, £m APE |
38 |
|
Table 10: Forecast income protection distribution 2007-2011, £m APE |
40 |
|
Table 11: Forecast stand alone critical illness distribution 2007-2011, £m APE |
42 |
|
List of Figures |
|
|
Figure 1: Income Protection continues to play a niche role in the UK protection market |
10 |
|
Figure 2: Accelerated and standalone CII policies have both been experiencing poor sales performances |
12 |
|
Figure 3: Individual IP sales saw further declines in 2005 but not as strong as a year earlier |
13 |
|
Figure 4: Income protection new business vs business in force |
14 |
|
Figure 5: Critical Illness new business vs business in force |
15 |
|
Figure 6: New business in stand-alone critical illness products is forecast to increase by a compound annual rate of 5.7%. |
17 |
|
Figure 7: In CII, the top 5 players share more than 50% of the UK market among them |
27 |
|
Figure 8: In IP, the top 5 players share almost two-thirds of the UK market among them |
29 |
|
Figure 9: Bancassurers have lost a significant proportion of market share in the income protection market |
35 |
|
Figure 10: Single ties sales of Critical illness have declined since 2004 |
37 |
|
Figure 11: Multi-tie financial advisors are forecast to make inroads into the income protection market between 2007 and 2011 |
39 |
|
Figure 12: Independent advisors will retain their majority share of the critical illness market |
41 |